Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phenylalanine hydroxylase mRNA rescues the phenylketonuria phenotype in mice.
Cacicedo ML, Weinl-Tenbruck C, Frank D, Limeres MJ, Wirsching S, Hilbert K, Pasha Famian MA, Horscroft N, Hennermann JB, Zepp F, Chevessier-Tünnesen F, Gehring S. Cacicedo ML, et al. Among authors: gehring s. Front Bioeng Biotechnol. 2022 Oct 7;10:993298. doi: 10.3389/fbioe.2022.993298. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36277393 Free PMC article.
mRNA-Based Approaches to Treating Liver Diseases.
Cacicedo ML, Limeres MJ, Gehring S. Cacicedo ML, et al. Among authors: gehring s. Cells. 2022 Oct 21;11(20):3328. doi: 10.3390/cells11203328. Cells. 2022. PMID: 36291194 Free PMC article. Review.
Cytotoxic Screening and Enhanced Anticancer Activity of Lippia alba and Clinopodium nepeta Essential Oils-Loaded Biocompatible Lipid Nanoparticles against Lung and Colon Cancer Cells.
Rodenak-Kladniew B, Castro MA, Gambaro RC, Girotti J, Cisneros JS, Viña S, Padula G, Crespo R, Castro GR, Gehring S, Chain CY, Islan GA. Rodenak-Kladniew B, et al. Among authors: gehring s. Pharmaceutics. 2023 Jul 29;15(8):2045. doi: 10.3390/pharmaceutics15082045. Pharmaceutics. 2023. PMID: 37631258 Free PMC article.
A phase 3, randomised, observer-blinded, placebo controlled-trial evaluating the safety and immunogenicity of investigational SARS-CoV-2 mRNA vaccine CVnCoV in adult healthcare workers in Mainz (Germany).
Kowalzik F, Teschner D, Mesquita M, Jensen C, Schreiner D, Kronfeld K, Tubic-Grozdanis M, Cheatham-Seitz D, Hettich F, Quintini G, Schoenborn-Kellenberger O, Codó P, von Eisenhart-Rothe P, Mann P, Oostvogels L, Gehring S. Kowalzik F, et al. Among authors: gehring s. Vaccine X. 2024 Jun 20;19:100512. doi: 10.1016/j.jvacx.2024.100512. eCollection 2024 Aug. Vaccine X. 2024. PMID: 39040887 Free PMC article.
102 results